MAZE · Categories · Form 4
MAZE - SEC Form 4 insider transactions
Maze Therapeutics Inc. (MAZE) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for MAZE
- SEC Form 4 filed by Bernstein Harold4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SEC Form 4 filed by Bachrodt Amy4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SEC Form 4 filed by Dandekar Atul4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SEC Form 4 filed by Kumar Neil4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SEC Form 4 filed by Bernstein Harold4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- President, R&D & CMO Bernstein Harold exercised 30,000 shares at a strike of $10.42 and sold $1,513,560 worth of shares (30,000 units at $50.45) (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SEC Form 4 filed by GC and Corp. Secretary Courtney Phillips4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Coloma Jason V4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- President, R&D & CMO Bernstein Harold exercised 15,000 shares at a strike of $10.42 and sold $690,334 worth of shares (15,000 units at $46.02) (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SVP, Finance Bachrodt Amy exercised 5,000 shares at a strike of $10.42 and sold $230,219 worth of shares (5,000 units at $46.04) (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- CSBO Dandekar Atul exercised 7,500 shares at a strike of $10.42 and sold $331,990 worth of shares (7,500 units at $44.27) (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SVP, Finance Bachrodt Amy exercised 5,000 shares at a strike of $10.42 and sold $227,612 worth of shares (5,000 units at $45.52) (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- President, R&D & CMO Bernstein Harold exercised 25,156 shares at a strike of $10.42 and sold $1,011,299 worth of shares (25,156 units at $40.20) (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- Director Sohn Catherine A. exercised 29,413 shares at a strike of $10.42 and sold $1,149,054 worth of shares (29,413 units at $39.07) (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- President, R&D & CMO Bernstein Harold exercised 4,844 shares at a strike of $10.42 and sold $195,668 worth of shares (4,844 units at $40.39) (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SVP, Finance Bachrodt Amy exercised 5,000 shares at a strike of $10.42 and sold $195,754 worth of shares (5,000 units at $39.15) (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- CSBO Dandekar Atul exercised 72,500 shares at a strike of $10.42 and sold $2,940,799 worth of shares (72,500 units at $40.56) (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- President, R&D & CMO Bernstein Harold exercised 45,000 shares at a strike of $10.42 and sold $1,825,355 worth of shares (45,000 units at $40.56) (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SVP, Finance Bachrodt Amy exercised 15,000 shares at a strike of $10.42 and sold $606,173 worth of shares (15,000 units at $40.41) (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- Director Homcy Charles J acquired 1,489 shares, increasing direct ownership by 5% to 31,113 units (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- Large owner Third Rock Ventures Iv, L.P. disposed of 1,600,000 shares (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- Director Homcy Charles J gifted 28,423 shares, decreasing direct ownership by 49% to 29,624 units (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SEC Form 4 filed by Director Hoppenot Herve4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SEC Form 4 filed by GC and Corp. Secretary Courtney Phillips4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SEC Form 4 filed by CSBO Dandekar Atul4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Coloma Jason V4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SEC Form 4 filed by President, R&D & CMO Bernstein Harold4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SEC Form 4 filed by SVP, Finance Bachrodt Amy4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SEC Form 4 filed by Director Spiegelman Daniel K4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SEC Form 4 filed by Director Sohn Catherine A.4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SEC Form 4 filed by Director Scheller Richard H4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SEC Form 4 filed by Director Lim Jonathan E4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SEC Form 4 filed by Director Kathiresan Sekar4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SEC Form 4 filed by Director Homcy Charles J4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SEC Form 4 filed by Director Exter Neil4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SEC Form 4 filed by Director Andrews Nancy C4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- Director Scheller Richard H sold $464,035 worth of shares (20,744 units at $22.37), closing all direct ownership in the company (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Tahir Misbah4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- SEC Form 4 filed by Director Exter Neil4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- Large owner Third Rock Ventures Iv, L.P. converted options into 6,713,588 shares (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- Director Lim Jonathan E converted options into 307,956 shares (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
- Director Homcy Charles J converted options into 36,946 shares, increasing direct ownership by 104% to 58,047 units (SEC Form 4)4 - Maze Therapeutics, Inc. (0001842295) (Issuer)